Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Transplantation and Cellular Therapy|October 7, 2023
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Tania Jain, et al.
Transplantation and Cellular Therapy|September 14, 2024
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, et al.
Transplantation and Cellular Therapy|June 20, 2022
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell TransplantationOk-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Transplantation and Cellular Therapy|February 4, 2023
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell TransplantationMohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Blood Reviews|July 7, 2026
What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapySanghee Hong, Manuel Ricardo Espinoza-Gutarra, Rahul Shah, et al.
Transplantation and Cellular Therapy|June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysisNeela Easton, Mia Andreoli, Herman van Besien, et al.
Transplantation and Cellular Therapy|November 5, 2022
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab RecipientsChandni Patel, Michelle Pasciolla, Rachel Abramova, et al.
Pageof 3